Observational studyThoracic cancer2022

Elevated neutrophil-to-lymphocyte ratio (NLR) is associated with poorer progression-free survival in unresectable stage III NSCLC treated with consolidation durvalumab.

Udit Nindra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.